Our People

At Myriad, our passion for patients drives everything we do – on the job and in the community.

Our Products

Myriad is answering patients’ most pressing questions about disease.

Our Pipeline

Myriad has the deepest diagnostic pipeline across the disease spectrum.

The Science

At Myriad, we’re leveraging our unique expertise in sequencing and analysis to better understand human disease.

myRisk® Hereditary Cancer

The Myriad myRisk® Hereditary Cancer test is a 28-gene panel that identifies an elevated risk for eight important cancers.

Prolaris®

Prolaris®

Prolaris aids healthcare professionals in predicting prostate cancer aggressiveness and disease progression.

GeneSight®

GeneSight meets a significant unmet clinical need and is the leading product for psychotropic drug selection.

Breaking News

Friday, September 15, 2017

Myriad Genetics Announces Positive Data Supporting New riskScore™ Test at the 36th Annual Conference of the National Society of Genetic Counselors

Tuesday, September 12, 2017

Myriad Genetics to Present Three Studies at the 2017 National Society of Genetic Counselors Annual Conference
Read News

Vectra® DA

Vectra DA is an advanced blood test that measures rheumatoid arthritis disease activity.

EndoPredict®

Helping Doctors guide ER+, HER2- early-stage breast cancer patients toward the appropriate treatment decision.

Hereditary Cancer Quiz

Take a 30-second quiz to help you find out if you’re at risk of hereditary cancer.

Events

Myriad Genetics Fourth Quarter Fiscal 2017 Financial Results Conference Call
Aug 8, 2017
4:30 PM ET

Listen to Webcast

Myriad Blog

View Blog